CRDMO Trademark

Trademark Overview


On Friday, December 6, 2024, a trademark application was filed for CRDMO with the United States Patent and Trademark Office. The USPTO has given the CRDMO trademark a serial number of 98888674. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 8, 2025. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The CRDMO trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

custom assembling of materials for others; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; custom production of biological preparations; processing of biomedical preparations; processing of biotechnology drug; processing of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals;

consulting services in the field of technology development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biological research; biomedical research services; veterinary research; biotechnology research;
crdmo

General Information


Serial Number98888674
Word MarkCRDMO
Filing DateFriday, December 6, 2024
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, September 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicescustom assembling of materials for others; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; custom production of biological preparations; processing of biomedical preparations; processing of biotechnology drug; processing of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals;
Goods and Servicesconsulting services in the field of technology development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biological research; biomedical research services; veterinary research; biotechnology research;

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, December 6, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 6, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCOUNTY LOUTH A91X56F
IE

Trademark Events


Event DateEvent Description
Friday, December 6, 2024NEW APPLICATION ENTERED
Sunday, April 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 19, 2025ASSIGNED TO EXAMINER
Friday, May 23, 2025NON-FINAL ACTION E-MAILED
Friday, May 23, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 23, 2025NON-FINAL ACTION WRITTEN
Monday, September 8, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, September 8, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND